Phibro Animal Health | PAHC - 流动负债

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	流动负债	更改		日
Align Technology	USD 1.92B		46.45M	2025-12
ANI Pharmaceuticals	USD 278.11M		7.56M	2025-12
Assertio Holdings	USD 166.78M		34.25M	2025-09
Aurora Cannabis	CAD 145.94M		21.82M	2025-12
Bristol-Myers Squibb	USD 28.14B		608M	2025-09
Canopy Growth	CAD 98.29M		17.19M	2025-12
Corcept Therapeutics	USD 166.08M		6.18M	2025-12
Eli Lilly	USD 35.23B		4.91B	2025-12
Henry Schein	USD 3.23B		79M	2025-12
Idexx Laboratories	USD 1.15B		103M	2025-12
Knight Therapeutics	CAD 165.26M		12.58M	2025-12
Merck	USD 28.63B		2.59B	2025-09
Nektar Therapeutics	USD 66.34M		5.05M	2025-09
Pacira	USD 120.59M		13.51M	2025-12
Phibro Animal Health	USD 282.37M		12.23M	2025-12
Prestige Brands	USD 139.56M		4.95M	2025-12
Supernus Pharmaceuticals	USD 338.17M		7.54M	2025-12
Zoetis	USD 2.24B		428M	2025-12